Evidence-Based Complementary and Alternative Medicine

Evidence-Based Complementary and Alternative Medicine / 2018 / Article

Research Article | Open Access

Volume 2018 |Article ID 6057579 | 9 pages | https://doi.org/10.1155/2018/6057579

Anti-Inflammatory and Antioxidant Properties of the Extract, Tiliroside, and Patuletin 3-O-β-D-Glucopyranoside from Pfaffia townsendii (Amaranthaceae)

Academic Editor: Maria G. Miguel
Received15 May 2018
Revised03 Aug 2018
Accepted27 Aug 2018
Published30 Sep 2018


Brazilian ginseng, including Pfaffia townsendii, is used in popular medicine as a natural anti-inflammatory, tonic, analgesic, and antidiabetic agent. In this study, we investigated the chemical composition and evaluated the antioxidant and anti-inflammatory activities of the P. townsendii ethanolic extract as well as the major isolated glycoside flavonoids tiliroside and patuletin 3-O-β-D-glucopyranoside. Chromatographic techniques and spectroscopic analysis were used for the isolation and identification of the major compounds. The antioxidant potential was determined through DPPH and ORAC-FL assays. The total phenolic content was measured using Folin-Ciocalteu reagent. The anti-inflammatory activity was determined based on a model of paw edema and carrageenan- (Cg-) induced pleurisy. We identified three phenolic acids, one carboxylic acid and two flavonoids, patuletin 3-O-β-D-glucopyranoside, and tiliroside. The ethanol crude extracts, partitions and isolated flavonoids (4581 μmol of Trolox equivalents/g of extract in ORAC and a SC50 of approximately 31.9 μg/mL in the DPPH assay) demonstrated antioxidant activity, and the ethanolic extract as well as isolated flavonoids inhibited paw edema induced by Cg and leukocyte migration in the Cg-induced pleurisy model. The extract, tiliroside, and patuletin 3-O-β-D-glucopyranoside obtained from P. townsendii have therapeutic potential against oxidative stress-related and inflammatory disorders.

1. Introduction

In Brazil, species of the genus Pfaffia (Amaranthaceae) are sold in the market as substitutes for Panax spp. (Ginseng, Araliaceae) because their roots are very similar. The population uses the popular “Brazilian ginseng” because of its anti-inflammatory, antistress [1], aphrodisiac, tonic, analgesic, and antidiabetic properties [2, 3]. The species acts against inflammation [1], cancer, gastric disorders, and rheumatism [3, 4] and is used to prevent premature aging, colic, and enteritis [5, 6].

Pharmacological studies have demonstrated that Pfaffia species are promising for the development of new molecules or therapies because they contain compounds with anti-inflammatory and analgesic activities [7, 8], as well as compounds that protect the gastric mucosa against lesions [4] and that have antioxidant [9] and antineoplastic activities [10].

Studies have shown that species of the Amaranthaceae family are able to accumulate phenolic substances, which have antioxidant activity, scavenge free radicals, protect against lipid peroxidation, and quench reactive oxygen species [11, 12]. Oxidative stress is present in some diseases such as cancers [13], cardiovascular disorders [14], inflammatory arthritis [15], and Alzheimer’s disease [16].

Glycoside flavonoids, such as tiliroside and patuletin 3-O-β-D-glucopyranoside, are found in several plants and are interesting because they could be responsible for the medicinal activity of these plants. For example, tiliroside has the ability to inhibit iNOX and COX-2 expression as well as MAPK/JNK/p38-mediated inflammation in LPS-stimulated macrophages in vitro [17]. Velagapud et al. (2014) also showed that tiliroside has in vitro inhibitory activity in microglia during neuroinflammation through a mechanism involving the TRAF-6-mdiated activation of the NF-κB and p38 MAPK signaling pathways [18]. This compound has been shown to exhibit anti-inflammatory activity in a TPA model and against phospholipase A2-induced edema and to have antioxidant and hepatoprotective activities [19]. Patuletin and its derivatives also show biological activity. Jabeen et al. (2016) revealed the anti-inflammatory and antiarthritic activities of patuletin in rodent models [20], whereas Li et al. (1991) showed that patuletin inhibits rat lens aldose reductase [21]. Additionally, patuletin acetylrhamnoside derivatives from Kalanchoe brasiliensis act as inhibitors of human lymphocyte proliferative activity.

All these facts prompted us to investigate the chemical composition and evaluate the antioxidant and anti-inflammatory activities of the Pfaffia townsendii ethanolic extract (EEPT) and its major isolated glycoside flavonoids tiliroside and patuletin 3-O-β-D-glucopyranoside.

2. Materials and Methods

2.1. Plant Material

Plants of P. townsendii were collected at Pico das Almas (Bahia, Brazil) and identified by Professor Josafá Carlos de Siqueira (Pontificia Universidade Catolica, Rio de Janeiro). A voucher specimen was deposited at the Herbarium at the Faculty of Philosophy, Sciences and Letters of Ribeirão Preto- (FFCLRP-) USP under register number NPL396.

2.2. Extraction and Isolation of Compounds

Whole P. townsendii plants were dried in an open stove at 40°C and powdered, affording 100 g. Exhaustive extraction with ethanol after hexane extraction gave 9.8 g of the hexane crude extract and 38 g of the ethanol crude extract (dry weight). The ethanol extract of P. townsendii (EEPT, 35 g) was suspended in MeOH/H2O (9:1, v/v) and partitioned with hexane, resulting in hexanic phase after removal of the solvent in a rotary evaporator (2 g). To the remaining hydroalcoholic phase water was added up to 40% and extracted with dichloromethane, resulting in the dichloromethane phase after removal of the solvent in a rotary evaporator (11 g). The remaining hydroalcoholic phase after removal of the solvent in a rotary evaporator, followed by the lyophilization (20 g), was subjected to fractionation using column chromatography with a Sephadex LH-20 stationary phase and MeOH mobile phase. Sixty-eight fractions were obtained after TLC analysis (using silica gel plates and butanol/acetic acid/water (65:15:25, v/v/v) as the mobile phase) and were pooled into 20 fractions. In fraction 8 (115 mg) and fractions 13-18 (130 mg) yellow precipitate was observed, that, after washing with cold ether, resulted, respectively, in isolated flavonoids patuletin 3-O-β-D-glucopyranoside (yield = 70 mg) and tiliroside (yield = 110 mg). These isolated compounds were identified by spectroscopic analyses (IR, UV, 1H NMR, 13C NMR, Dept. 135°, and HMBC) and ESI-MS/MS and comparison with the literature data [2225].

2.3. HPLC-DAD and ESI-MS Analyses

The EEPT and partitions were diluted in a solution containing 50% (v/v) chromatography-grade methanol, 50% (v/v) deionized water, and 0.5% ammonium hydroxide. In the fingerprinting ESI-MS analysis, the general conditions were as follows: source temperature, 100°C; capillary voltage, 3.0 kV; and cone voltage, 30 V. For measurements in the negative-ion mode, ESI(-)-MS, 10.0 μL of concentrated NH4OH was added to the sample mixture to obtain a total volume of 1000 μL with a final concentration of 0.1%. ESI-MS was performed by direct infusion with a flow rate of 10 μL min mL−1 using a syringe pump. Structural analysis of single ions in the mass spectrum of each extract was performed by ESI-MS/MS. The ion with the m/z of interest was selected and submitted to 15–45 eV collisions with argon in the collision quadrupole. The compounds were identified by comparison of their ESI-MS/MS fragmentation spectra with standard samples [2628]. HPLC analyses were conducted using an RP-18 column (Lichrospher, 5 μm, 225∖4.6 mm, Merck). The mobile phase consisted of a linear gradient combining solvent A (acetonitrile) and solvent B (water/acetic acid, 99:1, v/v, pH = 2.88) as follows: 15% A (15 min), 15–20% A (7 min), 20% A (5 min), 20–40% A (5 min), 40% A (5 min), and 40–15% A (3 min). The analyses were performed in triplicate at a flow rate of 0.8 mL/min and with an injection volume of 20 μL. The UV-DAD detector was set to record between 200 and 600 nm, and the UV chromatograms were measured at 254 and 330 nm. Quantitative HPLC-ESI-MS analyses were performed on the EEPT to verify the contents of the isolated flavonoids patuletin 3-O-β-D-glucopyranoside and tiliroside in the sample.

2.4. Quantitative Determination of the Total Soluble Phenols

The extract and partitions dissolved in methanol were analyzed for their total soluble phenolic content according to the Folin-Ciocalteu colorimetric method [29, 30] using gallic acid as a reference. The results are expressed as mg of gallic acid equivalents (GAE) per gram of extract or fraction (mg of GAE/g). The analyses were performed in triplicate.

2.5. Assessment of Radical Scavenging Activity Using the DPPH Method

The antiradical activities of the extracts were determined using the stable 2,2-diphenyl-1-picrylhydrazyl (DPPH) radical [31]. The test was performed in 96-well microplates. Fifty microliters of a 250 μM DPPH solution in MeOH was added to a range of solutions of different concentrations (7 serial 3-fold dilutions to give a final range of 100 to 1.6 μg mL−1) of extracts to be tested in MeOH (10 μL). The absorbance at 517 nm was measured 30 min after the addition of each of the tested compounds, and the percentage of activity was calculated. Quercetin and 6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid (Trolox) were used as positive controls. All the samples were tested in triplicate. The antioxidant activity of each sample is expressed as the SC50 value, which is the concentration in μg mL−1 of each extract that scavenged 50% of the DPPH radicals. All the results are expressed as the mean of three different trials.

2.6. Evaluation of the Antioxidant Capacity by the ORAC Assay

The antioxidant capacity of the ethanolic extract was assessed by the oxygen radical absorbance capacity (ORAC) kinetic assay according to the method established by Ou and coworkers [32, 33] with modifications [12]. The data are expressed as micromoles of 6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid (Trolox) equivalents (TE) per gram of extract on a dry weight basis (μmol of TE/g) and as relative Trolox equivalents for pure compounds. Quercetin, vitexin, caffeic acid, and chlorogenic acid were used as positive controls. The analyses were performed in triplicate.

2.7. Animals

For the inflammation test, Swiss male (edema test) or female (pleurisy test) mice (25–35 g) were used. The animals were maintained under a 12 h light–dark cycle with a controlled humidity of 60–80% and temperature of 22±1°C. Food and water were administered ad libitum, and approved experimental protocols were followed (number 020/2014 by the Ethics Committee for Research on Laboratory Animal Use of the UFGD).

2.8. Paw Edema Model of Cg to Induce Inflammation

Male Swiss mice were treated with an oral dose of the EEPT (300 mg/kg), patuletin 3-O-β-D-glucopyranoside (1 mg/kg), tiliroside (1 mg/kg), and vehicle (control), which was administered 60 minutes before Cg. Cg (300 μg) was administered by a subcutaneous route in the right paw of 100 μL of a solution prepared with 0.9% saline to the groups cited before as well as the control group (treated only with vehicle, 0.9% saline) and the positive control group (treated with subcutaneous (s.c.) dexamethasone, 1 mg/kg). The left paw was injected with 100 μL of 0.9% saline. The measurements of paw volume changes were made with a digital water plethysmometer (from Panlab) at 1, 2, and 4 h after Cg injection [34].

2.9. Induction of Pleurisy

The same doses of the EEPT, patuletin 3-O-β-D-glucopyranoside, and tiliroside described in Section 2.8 were also used to treat different groups (three groups with n = 6) of female Swiss mice via an oral route (p.o.), whereas the control group received 0.9% saline (p.o.). The naïve group received 0.9% saline (p.o.) but did not receive Cg via an intrathoracic route (i.t.), and the last group received dexamethasone (1 mg/kg positive control) via the s.c. route [35]. An i.t. injection of a solution of 1% Cg (100 μL) and sterile saline (100 μL; only to the naïve mice) was administered, and after 4 h, the animals were killed. The thorax was opened to obtain the pleural exudate [36]. After lavage, an aliquot of 50 μL was diluted with Evans blue dye (1:20) and used to determine the total number of leukocytes in a Neubauer chamber. The protein content in the extravasated fluid was assessed by the Bradford method (Bioagency, Brazil).

2.10. Statistical Analysis

The data are reported as the means (%RSDs, relative standard deviations) of triplicate determinations. The statistical analyses were carried out using Microsoft Excel 2013 (Microsoft Corp., Redmond, WA, USA) and GraphPad Prism version 5.0 for Windows (GraphPad Software, San Diego, CA, USA). The data are presented as the means ± SEM. Differences between groups were evaluated by analysis of variance (one-way ANOVA) followed by the Newman–Keuls test. The number of animals per group is indicated in the figure legends. Statistical differences were considered significant at P < 0.05. Asterisks () denote a significant difference compared with the vehicle-treated group.

3. Results

3.1. Isolation of Flavonoids and Phytochemical Analysis

The ethanolic extract of P. townsendii was subjected to fractionation, and a phytochemical investigation of this extract led to the isolation of two flavonoids, patuletin 3-O-β-D-glucopyranoside and kaempferol 3-O-β-D-(6′′-O-(E)-p-coumaroyl) glucopyranoside or tiliroside (Figure 1).

This manuscript constitutes the first report of these compounds in P. townsendii. The three phenolic acids, one carboxylic acid and two flavonoids (Table 1), were detected by comparisons of their ESI-MS/MS fragmentation spectra with standard samples.

CompoundDeprotonated ions [M-H]-m/zMS/MS ions m/z

Malic acid13315 eV: 133→115
Caffeic acid17915 eV: 179→125
Quinic acid19125 eV: 191→173, 127, 111, 93, 85
Ferulic acid19515 eV: 193→178, 149, 134
Patuletin 3-O-β-D-glucopyranoside49315 eV: 493
Tiliroside59415 eV: 594→308, 288

3.2. Quantitative HPLC-MS Analysis of the Flavonoids

In the HPLC-MS analysis, the calibration curves of the isolated flavonoids patuletin and tiliroside were obtained using concentrations between 500 μg/mL and 5 μg/ml. The concentrations of these compounds in the EPPT were then calculated based on these curves. The sample showed patuletin 3-O-β-D-glucopyranoside and tiliroside contents of 2.45 μg/mg of extract (equation of the line, 13828.8x + 498331.0, R2 = 0.9955) and 4.74 μg/mg of extract (equation of the line, y = 21147.4x + 626421.6, R2 = 0.9920), respectively.

3.3. Antioxidant Analysis

The extracts showed antioxidant activity in DPPH assays, with SC50 values varying from 31.9 to 62.6 μg/mL. The crude hexane and the hexane phase partition yielded very low values, with inhibitory concentrations > 200. In DPPH assays, the highest antioxidant activity was exhibited by the ethanolic extract (SC50 = 31.9 μg/mL). Moreover, in the ORAC-FL kinetic assay, the extracts showed antioxidant capacity values between 10.0 and 4581 μmol of Trolox equivalents per gram of extract (μmol of TE/g), confirming the low antioxidant activity of the hexane extract and the hexane phase (Table 2). The total phenolic content was measured using the Folin-Ciocalteu reagent. The extracts showed good levels of phenolic compounds (3.3–2.0 mg GAE/g), justifying the antioxidant activity identified through both methods. The ethanolic extract and hydroalcoholic phase of the partition showed excellent results in the antioxidant assays. The antioxidant activities of the two flavonoids were evaluated by DPPH and ORAC assays, verifying that these isolated compounds also showed antioxidant activities (Table 2).

Ethanol extract
Phenol content
(mg of GAE/g)
DPPH assay,
ORAC assay
(µmol of TE/g)

Hexane crude extract< 1.13> 20013.0 (5.0)
Ethanol crude extract3.3 (6.3)62.6 (10.0)1555 (10.5)
Hexane phase1.0 (3.5)> 2002461 (9.7)
Dichloromethane phase2.5 (7.9)45.6 (6.3)5641 (4.9)
Hydroalcoholic phase2.0 (2.8)31.9 (7.7)4581 (7.7)

Patuletin 3-O-β-D-glucopyranoside-4.9 (2.1)4.2 (6.9)

Tiliroside-83.2 (3.2)0.8 (3.4)

Mixture of patuletin 3-O-β-D-glucopyranoside + Tiliroside3.7 (2.5)4.8 (11.4)

Quercetin-8.3 (2.1)5.6 (0.9)
Caffeic acid-11.2 (2.4)2.9 (2.0)
Trolox-2.8 (1.8)-

Mean value (%RSD, relative standard deviation) of triplicate assays. Total phenolics data expressed as mg of gallic acid equivalents per g (mg of GAE/g). DPPH assay data expressed as SC50 (concentration that inhibited 50% of the DPPH radical) in μg per mL. ORAC data expressed as μmol of Trolox equivalents per g (µmol of TE/g). ORAC data expressed as relative Trolox equivalent, mean (%RSD, relative standard deviation) of triplicate assays. Experimental positive controls: not evaluated.
3.4. Effect of the Ethanol Extract of the EEPT and Isolated Flavonoids on Cg-Induced Paw Edema

In the paw inflammatory model, a dose of 300 mg/kg of the EEPT reduced the paw volume by 2 h (with a maximal inhibition of 51.00 ± 11.0% compared to the control), as observed 4 h after the Cg injection (Figure 2). Moreover, our results showed that a dose of 1.0 mg/kg of the flavonoids yielded maximal inhibition 240 min after the administration of tiliroside (73.00 ± 4.0%, P < 0.001) and patuletin 3-O-β-D-glucopyranoside (75.4 ± 4.0%, P < 0.001) compared with the control, as indicated by the time course analysis (Figure 2(c)). As expected, the inflammatory parameter was significantly reduced in the Cg-induced inflammatory process by treatment with dexamethasone.

3.5. Effect of the Ethanol Extract of the EEPT and Isolated Flavonoids on Cg-Induced Leukocyte Migration into the Pleura

The animals treated with the EEPT at a dose of 300 mg/kg, tiliroside (1.0 mg/kg), and patuletin 3-O-β-D-glucopyranoside (1.0 mg/kg) showed significant reductions in leukocyte migration induced by Cg in the pleural exudate (Figure 2(a)).

The EEPT showed an inhibition of 69.2 ± 1.04% compared with the vehicle group (Figure 3(a)). The naïve group, as expected, did not demonstrate inflammatory parameters in the analysis. The animals that were pretreated with the EEPT showed a plasma leakage of 72.0 ± 0.49%, which is higher than that observed in the animals pretreated with the vehicle (Figure 3(b)). As expected, the number of leukocytes and amount of protein in the pleural exudate were significantly reduced by treatment with dexamethasone.

The isolated flavonoids (patuletin 3-O-β-D-glucopyranoside and tiliroside) significantly reduced leukocyte migration (mainly polymorphonuclear cells) to the cavity, as illustrated in Figure 3(c), by 50.7 ± 1.03% and 59.4 ± 1.25%, respectively, compared with the vehicle group. In addition, the animals treated with patuletin 3-O-β-D-glucopyranoside and tiliroside showed decreased plasma leakage values of 13.3 ± 0.65% and 40.0 ± 0.46%, respectively, compared with those pretreated with the vehicle (Figure 3(d)).

4. Discussion

The present study provides the first demonstration of the antioxidant and anti-inflammatory properties of P. townsendii. These properties could be related to the four phenolic acids and two flavonoids found in our phytochemical studies. Both properties were positively verified by testing patuletin 3-O-β-D-glucopyranoside and tiliroside individually under the same conditions as the EEPT, indicating that the two flavonoids are important to P. townsendii and may contribute to the validation of the folk medicinal uses of Brazilian ginseng, such as anti-inflammatory, analgesic, and antidiabetic uses [3, 4].

The identification of the phenolic acids, carboxylic acid, and flavonoids in P. townsendii is in agreement with the literature regarding the Amaranthaceae family [10, 12]. The presence of the flavonoids tiliroside and patuletin 3-O-β-D-glucopyranoside in the Amaranthaceae family is also well known, and other studies have identified such glycosylated flavonoids [37, 38]. However, this is the first time that these flavonoids have been identified in P. townsendii.

The study showed that the EEPT extract from P. townsendii (Table 2) exhibit excellent antioxidant activity. In accordance with the literature, samples with values ≥1000.0 μmol of TE/g can be considered to have good antioxidant capacity [32, 33]. The dichloromethane phase (5641 μmol of TE/g) and hydroalcoholic phase (4581 μmol of TE/g) of partition meet this criterion. The hydroalcoholic phase as fractionated and gave rise to the patuletin 3-O-β-D-glucopyranoside and tiliroside flavonoids. The DPPH and ORAC antioxidant analyses of the isolated flavonoids showed excellent antioxidant results, a fact that justifies future biological surveys of P. townsendii because the antioxidant capacity of flavonoids confers a preventive and therapeutic potential in cardiovascular diseases [39], cancer [40, 41], and bacterial infections [42]. Sala et al. showed the antioxidant properties of tiliroside in enzymatic lipid peroxidation, nonenzymatic lipid peroxidation, scavenging, and the DPPH test (high potency) [19]. Their antiviral actions [43] as well as antiallergic and anti-inflammatory properties [44] are also important. The increase in the interest in flavonoids as a health benefit has increased due to their potential activity against free radicals and antioxidant power in in vitro analyses because increases in free radicals are related to some types of diseases [1416].

The ethanolic extract of P. townsendii inhibited edema formation and protein extravasation and had an inhibitory effect on leukocyte recruitment induced by Cg, which suggests that the fraction possesses compounds that are potentially anti-inflammatory. This was confirmed by the anti-inflammatory evaluation of isolated flavonoids from the ethanolic extract, tiliroside, and patuletin 3-O-β-D-glucopyranoside (Figure 2). One study demonstrated the inhibition of the expression of iNOX, and COX-2 as well as the MAPK/JNK/p38-mediated inflammatory process in vivo in LPS-stimulated macrophages [17], showing the in vivo anti-inflammatory activity of tiliroside in mice. Some studies have shown that tiliroside has anti-inflammatory activity [1719]. In an in vivo inflammatory assay, mouse paw edema induced by phospholipase A was inhibited by tyrosine with an activity at 35.6 mg/kg [19]. Jabeen et al. [20] indicated the anti-inflammatory and antiarthritic activities of patuletin 3-O-β-D-glucopyranoside in rodent models. The present work confirmed the efficacy of tiliroside and showed the high potency of this compound in the inhibition of the recruitment of additional immune cells, capillary leakage (indirectly verified by the protein dosage in pleura), and edema. The presence of patuletin 3-O-β-D-glucopyranoside and tiliroside contributes to the anti-inflammatory effects of P. townsendii.

The anti-inflammatory effect of patuletin 3-O-β-D-glucopyranoside is very similar to that of the dexamethasone control (Figures 2 and 3(c)): the flavonoid significantly reduces the increase in vascular permeability and the entrance of immune cells into tissues at the site of an inflammatory reaction (Figure 3(d)). These results confirmed previous observations showing that patuletin 3-O-β-D-glucopyranoside significantly inhibits histamine-induced hind-paw edema [45]. The results confirm that patuletin 3-O-β-D-glucopyranoside is effective in the treatment of acute inflammation by suppressing the chemical mediators of inflammation. This activity was previously indicated for flavonoids based on the inhibition of inflammation in experimental models through inhibition of the expression of inducible nitric oxide synthase (iNOS), cyclooxygenase (COX), and lipoxygenase (LOX) and subsequent decreases in nitric oxide (NO), prostanoids, leukotrienes, and other mediators of the inflammatory process, such as cytokines, chemokines, or adhesion molecules [4648].

These results suggest that the anti-inflammatory effects of P. townsendii are related to the presence of the flavonoids patuletin 3-O-β-D-glucopyranoside and tiliroside (Supplementary Material (available here)).

5. Conclusion

The results of the present study justify the popular use of Pfaffia because extracts of P. townsendii showed excellent antioxidant activity, as demonstrated by DPPH radical scavenging activity and ORAC assays. The study also found that the extract shows notable anti-inflammatory activity in vivo, and this activity is associated with the presence of the flavonoids patuletin 3-O-β-D-glucopyranoside and tiliroside. To the best of our knowledge, this report constitutes the first demonstration that the extract of P. townsendii has remarkable pharmacological activities related to the presence of flavonoids. Thus, P. townsendii may be considered a promising source of antioxidant and anti-inflammatory compounds such as phenolic acids and flavonoids.

Data Availability

The data used to support the findings of this study are available from the corresponding author upon request.

Conflicts of Interest

The authors declare that they have no conflicts of interest in this work.


The authors are grateful to CAPES, FUNDECT, CNPq, FAPESP, and FAEPEX-UNICAMP for the financial support and to Professor Josafá Carlos de Siqueira (PUC-RJ) for plant identification.

Supplementary Materials

The Supplementary Materials Description: “The P. townsendii shows notable anti-inflammatory activity in vivo, and this activity is associated with the presence of the flavonoids patuletin 3-O-β-D-glucopyranoside and tiliroside”. (Supplementary Materials)


  1. C. A. R. A. Costa, A. Tanimoto, A. E. V. Quaglio, L. D. Almeida, J. A. Severi, and L. C. Di Stasi, “Anti-inflammatory effects of Brazilian ginseng (Pfaffia paniculata) on TNBS-induced intestinal inflammation: Experimental evidence,” International Immunopharmacology, vol. 28, no. 1, pp. 459–469, 2015. View at: Publisher Site | Google Scholar
  2. E. Mendis, M.-M. Kim, N. Rajapakse, and S.-K. Kim, “An in vitro cellular analysis of the radical scavenging efficacy of chitooligosaccharides,” Life Sciences, vol. 80, no. 23, pp. 2118–2127, 2007. View at: Publisher Site | Google Scholar
  3. F. d. Oliveira, “Pfaffia paniculata (Martius) Kuntze: o ginseng-brasileiro,” Revista Brasileira de Farmacognosia, vol. 1, no. 1, pp. 86–92, 1986. View at: Publisher Site | Google Scholar
  4. C. S. Freitas, C. H. Baggio, J. E. da Silva-Santos et al., “Involvement of nitric oxide in the gastroprotective effects of an aqueous extract of Pfaffia glomerata (Spreng) Pedersen, Amaranthaceae, in rats,” Life Sciences, vol. 74, no. 9, pp. 1167–1179, 2004. View at: Publisher Site | Google Scholar
  5. J. C. Siqueira and T. S. M. Grandi, “O gênero Pfaffia Mart.(Amaranthaceae) nos cerrados e campos rupestres de Minas Gerais,” Acta Biologica Leopoldensia, vol. 8, pp. 213–230, 1986. View at: Google Scholar
  6. J. C. Siqueira, “Amaranthaceae de Mata Atlântica,” Acta Biologica Leopoldensia, vol. 12, pp. 173–165, 1990. View at: Google Scholar
  7. G. Mazzanti and L. Braghiroli, “Analgesic antiinflammatory action of Pfaffia paniculata (Martius) kuntze,” Phytotherapy Research, vol. 8, no. 7, pp. 413–416, 1994. View at: Publisher Site | Google Scholar
  8. S. F. Taniguchi, C. A. Bersani-Amado, L. S. Sudo, S. M. C. Assef, and S. Oga, “Effect of Pfaffia iresinoides on the experimental inflammatory process in rats,” Phytotherapy Research, vol. 11, no. 8, pp. 568–571, 1997. View at: Publisher Site | Google Scholar
  9. P. F. Leal, M. B. Kfouri, F. C. Alexandre et al., “Brazilian Ginseng extraction via LPSE and SFE: Global yields, extraction kinetics, chemical composition and antioxidant activity,” The Journal of Supercritical Fluids, vol. 54, no. 1, pp. 38–45, 2010. View at: Publisher Site | Google Scholar
  10. M. K. Nagamine, T. C. da Silva, P. Matsuzaki et al., “Cytotoxic effects of butanolic extract from Pfaffia paniculata (Brazilian Ginseng) on cultured human breast cancer cell line MCF-7,” Experimental and Toxicologic Pathology, vol. 61, no. 1, pp. 75–82, 2009. View at: Publisher Site | Google Scholar
  11. I. Amin, Y. Norazaidah, and K. I. E. Hainida, “Antioxidant activity and phenolic content of raw and blanched Amaranthus species,” Food Chemistry, vol. 94, no. 1, pp. 47–52, 2006. View at: Publisher Site | Google Scholar
  12. M. J. Salvador, E. O. Ferreira, S. U. Mertens-Talcott et al., “Isolation and HPLC quantitative analysis of antioxidant flavonoids from Alternanthera tenella Colla,” Zeitschrift fur Naturforschung - Section C Journal of Biosciences, vol. 61, no. 1-2, pp. 19–25, 2006. View at: Publisher Site | Google Scholar
  13. P. Mandal, “Potential biomarkers associated with oxidative stress for risk assessment of colorectal cancer,” Naunyn-Schmiedeberg’s Archives of Pharmacology, vol. 390, no. 6, pp. 557–565, 2017. View at: Publisher Site | Google Scholar
  14. K. Cervantes Gracia, D. Llanas-Cornejo, and H. Husi, “CVD and oxidative stress,” Journal of Clinical Medicine, vol. 6, no. 2, article 22, 2017. View at: Publisher Site | Google Scholar
  15. M. He, E. van Wijk, H. van Wietmarschen et al., “Spontaneous ultra-weak photon emission in correlation to inflammatory metabolism and oxidative stress in a mouse model of collagen-induced arthritis,” Journal of Photochemistry and Photobiology B: Biology, vol. 168, pp. 98–106, 2017. View at: Publisher Site | Google Scholar
  16. K. D. Jacob, N. N. Hooten, T. Tadokoro, A. Lohani, J. Barnes, and M. K. Evans, “Alzheimer’s disease-associated polymorphisms in human OGG1 alter catalytic activity and sensitize cells to DNA damage,” Free Radical Biology & Medicine, vol. 63, pp. 115–125, 2013. View at: Publisher Site | Google Scholar
  17. X. Jin, S. Song, J. Wang, Q. Zhang, F. Qiu, and F. Zhao, “Tiliroside, the major component of Agrimonia pilosa Ledeb ethanol extract, inhibits MAPK/JNK/p38-mediated inflammation in lipopolysaccharide-activated RAW 264.7 macrophages,” Experimental and Therapeutic Medicine, vol. 12, no. 1, pp. 499–505, 2016. View at: Publisher Site | Google Scholar
  18. R. Velagapudi, M. Aderogba, and O. A. Olajide, “Tiliroside, a dietary glycosidic flavonoid, inhibits TRAF-6/NF-κB/p38-mediated neuroinflammation in activated BV2 microglia,” Biochimica et Biophysica Acta (BBA) - General Subjects, vol. 1840, no. 12, pp. 3311–3319, 2014. View at: Publisher Site | Google Scholar
  19. A. Sala, M. C. Recio, G. R. Schinella et al., “Assessment of the anti-inflammatory activity and free radical scavenger activity of tiliroside,” European Journal of Pharmacology, vol. 461, no. 1, pp. 53–61, 2003. View at: Publisher Site | Google Scholar
  20. A. Jabeen, M. A. Mesaik, S. U. Simjee, Lubna, S. Bano, and S. Faizi, “Anti-TNF-α and anti-arthritic effect of patuletin: A rare flavonoid from Tagetes patula,” International Immunopharmacology, vol. 36, pp. 232–240, 2016. View at: Publisher Site | Google Scholar
  21. S. Li, W. Mao, X. Cao, S. Liang, Z. Ding, and N. Li, “Inhibition of rat lens aldose reductase by quercetagetin and patuletin,” Eye Science, vol. 7, no. 1, pp. 29–33, 1991. View at: Google Scholar
  22. M. Kaouadji, “Acylated and non-acylated kaempferol monoglycosides from Platanus acerifolia buds,” Phytochemistry, vol. 29, no. 7, pp. 2295–2297, 1990. View at: Publisher Site | Google Scholar
  23. Y. Wei, Q. Xie, D. Fisher, and I. A. Sutherland, “Separation of patuletin-3-o-glucoside, astragalin, quercetin, kaempferol and isorhamnetin from flaveria bidentis (L.) kuntze by elution-pump-out high-performance counter-current chromatography,” Journal of Chromatography A, vol. 1218, no. 36, pp. 6206–6211, 2011. View at: Publisher Site | Google Scholar
  24. T. Wu, R. Abdulla, Y. Yang, and H. A. Aisa, “Flavonoids from Gossypium hirsutum flowers,” Chemistry of Natural Compounds, vol. 44, no. 3, pp. 370-371, 2008. View at: Publisher Site | Google Scholar
  25. Q. Xie, Y. Wei, and G. Zhang, “Separation of flavonol glycosides from Flaveria bidentis (L.) Kuntze by high-speed counter-current chromatography,” Separation and Purification Technology, vol. 72, no. 2, pp. 229–233, 2010. View at: Publisher Site | Google Scholar
  26. M. J. Salvador, C. C. De Lourenço, N. L. Andreazza, A. C. R. F. Pascoal, and M. É. A. Stefanello, “Antioxidant capacity and phenolic content of four myrtaceae plants of the South of Brazil,” Natural Product Communications (NPC), vol. 6, no. 7, pp. 977–982, 2011. View at: Google Scholar
  27. J. G. Souza, R. R. Tomei, A. Kanashiro et al., “Ethanolic crude extract and flavonoids isolated from Alternanthera maritima: Neutrophil chemiluminescence inhibition and free radical scavenging activity,” Zeitschrift fur Naturforschung - Section C Journal of Biosciences, vol. 62, no. 5-6, pp. 339–347, 2007. View at: Publisher Site | Google Scholar
  28. M. Ye, J. Han, H. Chen, J. Zheng, and D. Guo, “Analysis of phenolic compounds in rhubarbs using liquid chromatography coupled with electrospray ionization mass spectrometry,” Journal of The American Society for Mass Spectrometry, vol. 18, no. 1, pp. 82–91, 2007. View at: Publisher Site | Google Scholar
  29. S. D'Aquino, M. Angioni, S. Schirru, and M. Agabbio, “Quality and Physiological Changes of Film Packaged 'Malvasio' Mandarins during Long Term Storage,” LWT- Food Science and Technology, vol. 34, no. 4, pp. 206–214, 2001. View at: Publisher Site | Google Scholar
  30. A. L. Piccinelli, F. De Simone, S. Passi, and L. Rastrelli, “Phenolic constituents and antioxidant activity of Wendita calysina leaves (burrito), a folk Paraguayan tea,” Journal of Agricultural and Food Chemistry, vol. 52, no. 19, pp. 5863–5868, 2004. View at: Publisher Site | Google Scholar
  31. M. Cuendet, K. Hostettmann, O. Potterat, and W. Dyatmiko, “Iridoid glucosides with free radical scavenging properties from Fagraea blumei,” Helvetica Chimica Acta, vol. 80, no. 4, pp. 1144–1152, 1997. View at: Publisher Site | Google Scholar
  32. D. Huang, B. Ou, and R. L. Prior, “The chemistry behind antioxidant capacity assays,” Journal of Agricultural and Food Chemistry, vol. 53, no. 6, pp. 1841–1856, 2005. View at: Publisher Site | Google Scholar
  33. B. Ou, M. Hampsch-Woodill, and R. L. Prior, “Development and validation of an improved oxygen radical absorbance capacity assay using fluorescein as the fluorescent probe,” Journal of Agricultural and Food Chemistry, vol. 49, no. 10, pp. 4619–4626, 2001. View at: Publisher Site | Google Scholar
  34. C. A. L. Kassuya, A. Cremoneze, L. F. L. Barros et al., “Antipyretic and anti-inflammatory properties of the ethanolic extract, dichloromethane fraction and costunolide from Magnolia ovata (Magnoliaceae),” Journal of Ethnopharmacology, vol. 124, no. 3, pp. 369–376, 2009. View at: Publisher Site | Google Scholar
  35. R. Vinegar, J. F. Truax, and J. L. Selph, “Some quantitative temporal characteristics of carrageenin-induced pleurisy in the rat,” Experimental Biology and Medicine, vol. 143, no. 3, pp. 711–714, 1973. View at: Publisher Site | Google Scholar
  36. L. N. F. Trevizan, K. F. D. Nascimento, J. A. Santos et al., “Anti-inflammatory, antioxidant and anti-Mycobacterium tuberculosis activity of viridiflorol: The major constituent of Allophylus edulis (A. St.-Hil., A. Juss. & Cambess.) Radlk.,” Journal of Ethnopharmacology, vol. 192, pp. 510–515, 2016. View at: Google Scholar
  37. E. O. Ferreira, M. J. Salvador, E. M. F. Pral, S. C. Alfieri, I. Y. Ito, and D. A. Dias, “A new heptasubstituted (E)-aurone glucoside and other aromatic compounds of Gomphrena agrestis with biological activity,” Zeitschrift fur Naturforschung - Section C Journal of Biosciences, vol. 59, no. 7-8, pp. 499–505, 2004. View at: Publisher Site | Google Scholar
  38. D. Mehta and S. Belemkar, “Pharmacological activity of spinacia oleracea linn,” Asian Journal of Pharmaceutical Research and Development, vol. 2, no. 1, 2014. View at: Google Scholar
  39. J. J. Peterson, J. T. Dwyer, P. F. Jacques, and M. L. McCullough, “Associations between flavonoids and cardiovascular disease incidence or mortality in European and US populations,” Nutrition Reviews, vol. 70, no. 9, pp. 491–508, 2012. View at: Publisher Site | Google Scholar
  40. L. Naso, M. Valcarcel, P. Villacé et al., “Specific antitumor activities of natural and oxovanadium(iv) complexed flavonoids in human breast cancer cells,” New Journal of Chemistry, vol. 38, no. 6, pp. 2414–2421, 2014. View at: Publisher Site | Google Scholar
  41. H. Yao, W. Xu, X. Shi, and Z. Zhang, “Dietary flavonoids as cancer prevention agents,” Journal of Environmental Science and Health - Part C Environmental Carcinogenesis and Ecotoxicology Reviews, vol. 29, no. 1, pp. 1–31, 2011. View at: Publisher Site | Google Scholar
  42. T. P. T. Cushnie and A. J. Lamb, “Recent advances in understanding the antibacterial properties of flavonoids,” International Journal of Antimicrobial Agents, vol. 38, no. 2, pp. 99–107, 2011. View at: Publisher Site | Google Scholar
  43. T. N. Kaul, E. Middleton Jr., and P. L. Ogra, “Antiviral effect of flavonoids on human viruses,” Journal of Medical Virology, vol. 15, no. 1, pp. 71–79, 1985. View at: Publisher Site | Google Scholar
  44. A. García-Lafuente, E. Guillamón, A. Villares, M. A. Rostagno, and J. A. Martínez, “Flavonoids as anti-inflammatory agents: implications in cancer and cardiovascular disease,” Inflammation Research, vol. 58, no. 9, pp. 537–552, 2009. View at: Publisher Site | Google Scholar
  45. K. Yasukawa and Y. Kasahara, “Effects of flavonoids from French Marigold (Florets of Tagetes patula L.) on acute inflammation model,” International Journal of Inflammation, vol. 2013, Article ID 309493, 5 pages, 2013. View at: Publisher Site | Google Scholar
  46. D. Camuesco, M. Comalada, M. E. Rodríguez-Cabezas et al., “The intestinal anti-inflammatory effect of quercitrin is associated with an inhibition in iNOS expression,” British Journal of Pharmacology, vol. 143, no. 7, pp. 908–918, 2004. View at: Publisher Site | Google Scholar
  47. I. Rahman, J. Marwick, and P. Kirkham, “Redox modulation of chromatin remodeling: impact on histone acetylation and deacetylation, NF-κB and pro-inflammatory gene expression,” Biochemical Pharmacology, vol. 68, no. 6, pp. 1255–1267, 2004. View at: Publisher Site | Google Scholar
  48. M. J. Tuñón, M. V. García-Mediavilla, S. Sánchez-Campos, and J. González-Gallego, “Potential of flavonoids as anti-inflammatory agents: modulation of pro-inflammatory gene expression and signal transduction pathways,” Current Drug Metabolism, vol. 10, no. 3, pp. 256–271, 2009. View at: Publisher Site | Google Scholar

Copyright © 2018 Wallace Ribeiro Corrêa et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

More related articles

1154 Views | 406 Downloads | 1 Citation
 PDF  Download Citation  Citation
 Download other formatsMore
 Order printed copiesOrder

Related articles

We are committed to sharing findings related to COVID-19 as quickly and safely as possible. Any author submitting a COVID-19 paper should notify us at help@hindawi.com to ensure their research is fast-tracked and made available on a preprint server as soon as possible. We will be providing unlimited waivers of publication charges for accepted articles related to COVID-19. Sign up here as a reviewer to help fast-track new submissions.